These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6751732)

  • 21. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Insulin and the metabolism of lipoproteins].
    Romon M; Thomas-Desrousseaux P; Beuscart R; Fossati P; Sezille G; Jaillard J
    Ann Endocrinol (Paris); 1983; 44(1):77-81. PubMed ID: 6347030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity and free fatty acids: double trouble.
    Castro Cabezas M; Halkes CJ; Erkelens DW
    Nutr Metab Cardiovasc Dis; 2001 Apr; 11(2):134-42. PubMed ID: 11434190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary causes of hyperlipidemia.
    Stone NJ
    Med Clin North Am; 1994 Jan; 78(1):117-41. PubMed ID: 8283927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus.
    Romics L; Karádi I; Rozenberczki M; Kammerer L
    Acta Med Acad Sci Hung; 1982; 39(3-4):117-23. PubMed ID: 6764327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diabetes mellitus complicated with hyperlipidemia].
    Ota Y; Gotoda T
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():424-9. PubMed ID: 12430264
    [No Abstract]   [Full Text] [Related]  

  • 27. [Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism].
    Krone W; Müller-Wieland D; Wirth H
    Fortschr Med; 1992 Dec; 110(34):645-8. PubMed ID: 1483617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary intake and hyperlipidemia in controlled diabetic outpatients.
    Maruhama Y; Abe R; Okuguchi F; Ohneda A
    Diabetes; 1977 Feb; 26(2):94-9. PubMed ID: 838168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding and treating dyslipidemia associated with noninsulin-dependent diabetes mellitus and hypertension.
    McKenney JM
    Pharmacotherapy; 1993; 13(4):340-52. PubMed ID: 8361860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.
    Nikkilä EA; Huttunen JK; Ehnholm C
    Diabetes; 1977 Jan; 26(1):11-21. PubMed ID: 187516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Very low density lipoprotein metabolism in diabetes mellitus.
    Ginsberg HN
    Diabetes Metab Rev; 1987 Apr; 3(2):571-89. PubMed ID: 3552533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Postprandial hyperlipidemia, small and dense LDL, HDL sub-fractions].
    Braschi S
    Ann Med Interne (Paris); 2001 Apr; 152(3):162-8. PubMed ID: 11431575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The therapeutic role of very low-density lipoprotein receptor gene in hyperlipidemia in type 2 diabetic rats.
    Yuan G; Liu Y; Sun T; Xu Y; Zhang J; Yang Y; Zhang M; Cianflone K; Wang DW
    Hum Gene Ther; 2011 Mar; 22(3):302-12. PubMed ID: 21087152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of metabolic dyslipidemia in insulin resistant states: deregulation of hepatic and intestinal lipoprotein secretion.
    Avramoglu RK; Qiu W; Adeli K
    Front Biosci; 2003 Jan; 8():d464-76. PubMed ID: 12456312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.
    Goa KL; Barradell LB; Plosker GL
    Drugs; 1996 Nov; 52(5):725-53. PubMed ID: 9118820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society.
    Eur Heart J; 1988 May; 9(5):571-600. PubMed ID: 3402474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of obesity in primary hyperlipidemias.
    Carmena R; Ascaso JF; Real JT
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
    Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes of lipoproteins during insulin therapy in diabetes mellitus type 1].
    Pantelinac P
    Med Pregl; 2009; 62 Suppl 3():66-9. PubMed ID: 19702119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic hypertriglyceridemia: evidence for three clinical syndromes.
    Reaven GM; Greenfield MS
    Diabetes; 1981; 30(Suppl 2):66-75. PubMed ID: 7028540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.